Fiduciary Family Office’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$797K Buy
28,367
+17,270
+156% +$460K 0.23% 84
2025
Q4
$276K Buy
11,097
+96
+0.9% +$2.42K 0.08% 149
2025
Q3
$280K Sell
11,001
-6,369
-37% -$157K 0.08% 158
2025
Q2
$421K Buy
17,370
+2,917
+20% +$68K 0.14% 129
2025
Q1
$366K Buy
+14,453
New +$378K 0.12% 140
2024
Q4
Sell
-19,989
Closed -$578K 201
2024
Q3
$578K Buy
19,989
+833
+4% +$24.3K 0.19% 111
2024
Q2
$536K Buy
19,156
+504
+3% +$13.9K 0.21% 123
2024
Q1
$518K Buy
18,652
+3,225
+21% +$89.5K 0.2% 131
2023
Q4
$444K Buy
+15,427
New +$466K 0.19% 131

Other funds holding PFE

Fiduciary Family Office's PFE Position: Q1 2026 in Review

Fiduciary Family Office increased its Pfizer (PFE) stake by 156% in Q1 2026, buying an estimated $460K and bringing the position to 28,367 shares worth $797K. The position accounts for 0.23% of the portfolio, ranked #84.

Fiduciary Family Office first reported a position in PFE in Q4 2023 and has held it in 9 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Fiduciary Family Office held 28,367 shares of Pfizer worth $797K as of Q1 2026.
  • Fiduciary Family Office bought 17,270 Pfizer shares in Q1 2026, an estimated $460K.
  • Pfizer made up 0.23% of Fiduciary Family Office's portfolio in Q1 2026, its #84 holding.
  • Fiduciary Family Office first reported a position in Pfizer in Q4 2023 and has held it in 9 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Fiduciary Family Office's 13F filing for Q1 2026, filed 14 May 2026.